Topas Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
8
Active:5
Completed:1
Trial Phases
2 Phases
Phase 1:6
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (85.7%)Phase 2
1 (14.3%)A Study to Assess the Safety of TPM502 in Adults With Celiac Disease
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Topas Therapeutics GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT05660109
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, Australia
🇦🇺Wesley Research Institute, Brisbane, Australia
🇫🇮CRST Oy, Turku, Finland
News
No news found